Skip to content

A prospective cohort study of anterior cervical corpectomy and fusion with zero-p self-stabilizing artificial vertebral body

A prospective cohort study of anterior cervical corpectomy and fusion with zero-p self-stabilizing artificial vertebral body

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300074118
Enrollment
Unknown
Registered
2023-07-31
Start date
2023-08-01
Completion date
Unknown
Last updated
2023-08-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cervical spondylotic myelopathy

Interventions

Zero-p vertebral body group:received ACCF with zero-p self-stabilizing artificial vertebral body, and were discharged routinely after operation.
Vertebral titanium plate group:received ACCF with artificial vertebral body and titanium plate, and were discharged routinely after operation.

Sponsors

Department of Orthopaedics & Institution of Spine Surgery, Peking University Third Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: Patients aged 18-70 years old, diagnosed with diseases below, planned to undergo single-segment ACCF, and signed informed consent. 1) Cervical spondylotic myelopathy 2) Cervical spondylotic radiculopathy 3) Mixed cervical spondylosis 4) Ossification of the posterior longitudinal ligament of the cervical spine 5) With/without mild cervical kyphosis (C2-7 Cobb angle < 10 degrees, kyphosis)

Exclusion criteria

Exclusion criteria: One of the following conditions will not be included in the study: 1) History of previous cervical spine surgery; 2) Patients undergoing hybird surgery with ACCF and ACDF 3) Severe osteoporosis (dual energy X-ray bone mineral density T value 30); 5) Patients with mental and nervous system diseases; 6) Patients with liver, kidney and blood system diseases and abnormal laboratory tests; 7) Patients with poor compliance; 8) Patients with other surgical contraindications; 9) Drug addicts or alcoholics; 10) Those who have participated in other clinical trials within 3 months.

Design outcomes

Primary

MeasureTime frame
Bazaz score;Implant subsidence (intervertebral height);

Secondary

MeasureTime frame
Cervical spine range of motion and sagittal balance parameter;NDI score;mJOA score;EQ-5D score;Neck VAS score;

Countries

China

Contacts

Public ContactFeifei Zhou

Department of Orthopaedics & Institution of Spine Surgery, Peking University Third Hospital

orthozhou@163.com+86 135 8178 7350

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026